Listed

Wrap Technologies, Inc.: Form 10-Q for the period ended Mar 31, 2022

Filed with the SEC on May 3, 2022 and accepted by EDGAR at May 3, 2022, 16:02 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-01-01 to 2022-03-31$1.6mus-gaap:Revenues
Cost of revenue3 months2022-01-01 to 2022-03-31$932.0kus-gaap:CostOfRevenue
Gross profit3 months2022-01-01 to 2022-03-31$667.0kus-gaap:GrossProfit
Research and development3 months2022-01-01 to 2022-03-31$1.5mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2022-01-01 to 2022-03-31$4.6mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-01-01 to 2022-03-31−$5.4mus-gaap:OperatingIncomeLoss
Net income3 months2022-01-01 to 2022-03-31−$5.4mus-gaap:NetIncomeLoss
Basic EPS3 months2022-01-01 to 2022-03-31−$0.13us-gaap:EarningsPerShareBasic
Operating cash flow3 months2022-01-01 to 2022-03-31−$4.8mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2022-01-01 to 2022-03-31$81.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2022-03-31$5.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-03-31$36.8mus-gaap:AssetsCurrent
Total assetsAt period end2022-03-31$40.1mus-gaap:Assets
Current liabilitiesAt period end2022-03-31$2.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-03-31$3.2mus-gaap:Liabilities
Shareholders' equityAt period end2022-03-31$36.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001851734-22-000227. Last ingested by Listed: Nov 6, 2026, 18:00 ET. Listed shows no prices and gives no investment advice.